IOB - Delayed Quote USD
Sanofi (0A2V.IL)
55.52
+1.18
+(2.17%)
At close: May 2 at 6:59:05 PM GMT+1
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
11,086,000
9,081,000
10,258,000
10,526,000
10,522,000
Investing Cash Flow
-4,811,000
-4,407,000
-6,200,000
-2,075,000
-7,298,000
Financing Cash Flow
-7,115,000
-5,763,000
-8,052,000
-5,821,000
-7,056,000
Other Cash Adjustment Inside Change in Cash
-321,000
-167,000
--
--
--
End Cash Position
8,019,000
7,441,000
8,710,000
12,736,000
10,098,000
Income Tax Paid Supplemental Data
--
3,291,000
2,623,000
2,452,000
1,280,000
Interest Paid Supplemental Data
--
587,000
559,000
380,000
334,000
Capital Expenditure
--
-3,195,000
-2,906,000
-2,103,000
-2,043,000
Issuance of Capital Stock
--
187,000
195,000
188,000
186,000
Issuance of Debt
--
--
48,000
1,549,000
--
Repayment of Debt
--
-953,000
-3,936,000
-2,998,000
-2,390,000
Repurchase of Capital Stock
--
-302,000
-593,000
-497,000
-382,000
Free Cash Flow
7,891,000
5,886,000
7,352,000
8,423,000
8,479,000
12/31/2021 - 11/6/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DSNKY Daiichi Sankyo Company, Limited
25.91
-0.12%
BAYRY Bayer Aktiengesellschaft
6.74
-0.15%
RHHBY Roche Holding AG
41.08
-0.12%
BIIB Biogen Inc.
123.53
+2.15%
GSK GSK plc
39.07
+0.83%
AZN AstraZeneca PLC
72.44
+2.74%
GILD Gilead Sciences, Inc.
103.68
+0.42%
BMY Bristol-Myers Squibb Company
50.57
+1.94%
OGN Organon & Co.
9.59
+1.48%
LLY Eli Lilly and Company
823.62
+3.72%